Unknown

Dataset Information

0

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer.


ABSTRACT: Triple-negative breast cancer (TNBC) is insensitive to endocrine and Her2-directed therapies, making the development of TNBC-targeted therapies an unmet medical need. Since patients with TNBC frequently show a quicker relapse and metastatic progression compared to other breast cancer subtypes, we hypothesized that cancer stem cells (CSC) could have a role in TNBC. To identify putative TNBC CSC-associated targets, we compared the gene expression profiles of CSC-enriched tumorspheres and their parental cells grown as monolayer. Among the up-regulated genes coding for cell membrane-associated proteins, we selected Teneurin 4 (TENM4), involved in cell differentiation and deregulated in tumors of different histotypes, as the object for this study. Meta-analysis of breast cancer datasets shows that TENM4 mRNA is up-regulated in invasive carcinoma specimens compared to normal breast and that high expression of TENM4 correlates with a shorter relapse-free survival in TNBC patients. TENM4 silencing in mammary cancer cells significantly impaired tumorsphere-forming ability, migratory capacity and Focal Adhesion Kinase (FAK) phosphorylation. Moreover, we found higher levels of TENM4 in plasma from tumor-bearing mice and TNBC patients compared to the healthy controls. Overall, our results indicate that TENM4 may act as a novel biomarker and target for the treatment of TNBC.

SUBMITTER: Ruiu R 

PROVIDER: S-EPMC7924390 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast Cancer.

Ruiu Roberto R   Barutello Giuseppina G   Arigoni Maddalena M   Riccardo Federica F   Conti Laura L   Peppino Giulia G   Annaratone Laura L   Marchiò Caterina C   Mengozzi Giulio G   Calogero Raffaele Adolfo RA   Cavallo Federica F   Quaglino Elena E  

Cancers 20210220 4


Triple-negative breast cancer (TNBC) is insensitive to endocrine and Her2-directed therapies, making the development of TNBC-targeted therapies an unmet medical need. Since patients with TNBC frequently show a quicker relapse and metastatic progression compared to other breast cancer subtypes, we hypothesized that cancer stem cells (CSC) could have a role in TNBC. To identify putative TNBC CSC-associated targets, we compared the gene expression profiles of CSC-enriched tumorspheres and their par  ...[more]

Similar Datasets

| S-EPMC4003203 | biostudies-other
| S-EPMC3415670 | biostudies-literature
| S-EPMC7642036 | biostudies-literature
| S-EPMC5955414 | biostudies-literature
| S-EPMC10873955 | biostudies-literature
| S-EPMC6797726 | biostudies-literature
| S-EPMC9235877 | biostudies-literature
| S-EPMC7036924 | biostudies-literature
| S-EPMC6518732 | biostudies-literature
| S-EPMC7539633 | biostudies-literature